Stock Updates

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) – Is this large market cap stock undervalued?

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), is firmly in the large market cap category with market cap of 14878.5. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for BioMarin Pharmaceutical Inc. is 86.63 (with a change from open of 0.37%), this in conjunction with a target price of 119.06. Volume today has so far reached 1068924, with an average volume of about 1568.02. The GAP for this stock, is -1.86%.

The P/E ratio is *TBA, bringing the forward P/E to a value of *TBA. The current EPS for BioMarin Pharmaceutical Inc., is -3.27, with a EPS growth for this year coming to a value of -17.30%. Performance has been interesting with performance year to date coming to -16.05%.

Looking further into the growth statistics for BioMarin Pharmaceutical Inc., EPS is looking like it will grow 73.20% in the next year. Looking even further it is projected to be 25.00%. Quarter over quarter is -409.70% for EPS growth and for sales growth quarter over quarter it is 20.00%. Looking at past EPS growth statistics we see that for the past five years it has been -21.30%. Sales growth for the past five years has in fact been 18.80%.

Looking at the ownership, we see that the insider ownership is at 0.60% and institutional ownership is 99.70%. Shares outstanding is 169.17, while shares float is at a value of 169.17. Float short for BioMarin Pharmaceutical Inc. is 4.08% and the short ratio is 4.4.

In terms of debt, long term debt/equity is 0.34, while the total debt/equity comes to 0.35. The ability to meet these debts, means that the current ratio is 3, and the quick ratio is 2.1. The most recent gross margin is 82.10% and their operating margin is -65.20%. The profit margin is -54.50%.

BioMarin Pharmaceutical Inc. has seen returns on assets of -15.10%, and on investment, -4.20%. Return on equity is -23.90%. Price/Earnings to growth ratio is *TBA. Price/Sales ratio is at a value of 15.28, with Price/book ratio coming to 7.46 and Price/cash is 29.56, and finally Price/Free cash Flow is *TBA.

The simple moving averages are -9.03% and -0.95% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -26.88% and the 52 week low is 39.46%.

BioMarin Pharmaceutical Inc. has a dividend yield of *TBA, with a current price of 86.63. The ability to pay this means the payout ratio is *TBA. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. BioMarin Pharmaceutical Inc. is based in USA.

Performance in the Biotechnology industry means that BioMarin Pharmaceutical Inc. has seen performance for the past week of -8.31%, with performance for the month coming to -6.32%. Looking at the data for the quarter it is at a value of -1.21%, and for the half year the performance is -14.54%. Volatility for this week is 3.53% and for the month this is 3.35%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment